Product testing conducted by the US Food and Drug Administration (FDA) has found that many CBD-infused products on sale in the United States are mislabeled, containing vastly differing amounts of CBD than advertised on the product packaging.
The new rule was initially meant to take effect on April 1, but delays were made amid the coronavirus pandemic.
With a steady increase of research into cannabinoids, and with changes to legalization and regulation, the future of the cannabis beverage industry will have to overcome considerable challenges to keep up with new consumer demands.
The new study could help determine how brain network patterns may change once consumers reduce their cannabis intake.
The cannabis and hemp testing company Kaycha Labs has become the first business in Florida to be awarded the state Department of Health’s certified marijuana testing laboratory status.